358 related articles for article (PubMed ID: 33803852)
1. Shiga Toxins: An Update on Host Factors and Biomedical Applications.
Liu Y; Tian S; Thaker H; Dong M
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803852
[TBL] [Abstract][Full Text] [Related]
2. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
Müthing J; Schweppe CH; Karch H; Friedrich AW
Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
[TBL] [Abstract][Full Text] [Related]
3. Molecular Biology of
Menge C
Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32456125
[TBL] [Abstract][Full Text] [Related]
4. CRISPR Screen Reveals that EHEC's T3SS and Shiga Toxin Rely on Shared Host Factors for Infection.
Pacheco AR; Lazarus JE; Sit B; Schmieder S; Lencer WI; Blondel CJ; Doench JG; Davis BM; Waldor MK
mBio; 2018 Jun; 9(3):. PubMed ID: 29921669
[TBL] [Abstract][Full Text] [Related]
5. Protection against Shiga Toxins.
Kavaliauskiene S; Dyve Lingelem AB; Skotland T; Sandvig K
Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28165371
[TBL] [Abstract][Full Text] [Related]
6. Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.
Detzner J; Pohlentz G; Müthing J
Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32512916
[TBL] [Abstract][Full Text] [Related]
7. The Role of
Menge C
Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32967277
[TBL] [Abstract][Full Text] [Related]
8. Shiga toxin-glycosphingolipid interaction: Status quo of research with focus on primary human brain and kidney endothelial cells.
Legros N; Pohlentz G; Steil D; Müthing J
Int J Med Microbiol; 2018 Dec; 308(8):1073-1084. PubMed ID: 30224239
[TBL] [Abstract][Full Text] [Related]
9. Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome.
Jeong YJ; Park SK; Yoon SJ; Park YJ; Lee MS
J Microbiol Biotechnol; 2018 Sep; 28(9):1413-1425. PubMed ID: 29926707
[TBL] [Abstract][Full Text] [Related]
10. Shiga Toxins as Antitumor Tools.
Robert A; Wiels J
Toxins (Basel); 2021 Sep; 13(10):. PubMed ID: 34678982
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide CRISPR screens for Shiga toxins and ricin reveal Golgi proteins critical for glycosylation.
Tian S; Muneeruddin K; Choi MY; Tao L; Bhuiyan RH; Ohmi Y; Furukawa K; Furukawa K; Boland S; Shaffer SA; Adam RM; Dong M
PLoS Biol; 2018 Nov; 16(11):e2006951. PubMed ID: 30481169
[TBL] [Abstract][Full Text] [Related]
12. The Fatal Role of Enterohaemorrhagic Escherichia coli Shiga Toxin-associated Extracellular Vesicles in Host Cells.
Lee KS; Park JY; Jeong YJ; Lee MS
J Microbiol; 2023 Aug; 61(8):715-727. PubMed ID: 37665555
[TBL] [Abstract][Full Text] [Related]
13.
Lee KS; Jeong YJ; Lee MS
Toxins (Basel); 2021 Jun; 13(6):. PubMed ID: 34208170
[No Abstract] [Full Text] [Related]
14. The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)--associated hemolytic-uremic syndrome.
Karch H
Semin Thromb Hemost; 2001 Jun; 27(3):207-13. PubMed ID: 11446654
[TBL] [Abstract][Full Text] [Related]
15. Enterohemorrhagic Escherichia coli suppresses inflammatory response to cytokines and its own toxin.
Bellmeyer A; Cotton C; Kanteti R; Koutsouris A; Viswanathan VK; Hecht G
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G576-81. PubMed ID: 19556613
[TBL] [Abstract][Full Text] [Related]
16. Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?
Bielaszewska M; Köck R; Friedrich AW; von Eiff C; Zimmerhackl LB; Karch H; Mellmann A
PLoS One; 2007 Oct; 2(10):e1024. PubMed ID: 17925872
[TBL] [Abstract][Full Text] [Related]
17. Human monocytes stimulated by Shiga toxin 1a via globotriaosylceramide release proinflammatory molecules associated with hemolytic uremic syndrome.
Brigotti M; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Valerii MC; Spisni E
Int J Med Microbiol; 2018 Oct; 308(7):940-946. PubMed ID: 29983334
[TBL] [Abstract][Full Text] [Related]
18. Shiga Toxin (Stx)-Binding Glycosphingolipids of Primary Human Renal Cortical Epithelial Cells (pHRCEpiCs) and Stx-Mediated Cytotoxicity.
Detzner J; Krojnewski E; Pohlentz G; Steil D; Humpf HU; Mellmann A; Karch H; Müthing J
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33673393
[TBL] [Abstract][Full Text] [Related]
19. Shiga toxin mode of action in E. coli O157:H7 disease.
Obrig TG
Front Biosci; 1997 Dec; 2():d635-42. PubMed ID: 9392626
[TBL] [Abstract][Full Text] [Related]
20. [Role of the Shiga toxin in the hemolytic uremic syndrome].
Creydt VP; Nuñez P; Boccoli J; Silberstein C; Zotta E; Goldstein J; Ibarra C
Medicina (B Aires); 2006; 66 Suppl 3():11-5. PubMed ID: 17354471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
